美股異動丨諾基亞(NOK.US)盤前漲逾3% 與Innventure宣佈冷卻技術商業化計劃
格隆匯6月14日丨諾基亞(NOK.US)盤前漲逾3%,報4.72美元。諾基亞和Innventure宣佈計劃將實現諾基亞貝爾實驗室為數據中心和移動網絡設備開發的冷卻技術商業化。Innventure成立了一家新公司Accelsius,該公司已從諾基亞獲得冷卻技術的權利,並將負責其進一步開發和商業化。冷卻技術直接為芯片或其他熱源提供冷卻。被動兩級冷卻液循環過程可實現高密度熱源的傳熱和散熱,無需使用泵。該冷卻解決方案適用於範圍廣泛的關鍵電子設備,並且可以以任何規模部署,從單個服務器到大型數據中心。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.